Rifampin 300 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DR26FL8QH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,897
Award facts
- Contract value 100% obligated
- $11,897.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, providing a comprehensive vehicle for global pharmaceutical support.
Rifampin is an essential antibiotic used in the treatment of tuberculosis and other mycobacterial infections, making this procurement integral to the Defense Health Agency's pharmaceutical inventory management. As a child contract under the SPE2DX prime vendor vehicle, this delivery order exemplifies AmerisourceBergen's role in supplying specialized pharmaceutical commodities to support military healthcare programs worldwide. The company's competitive positioning and extensive federal contract portfolio demonstrate its capability to fulfill critical medical supply requirements across multiple therapeutic domains for the Department of Defense and related federal healthcare organizations.
Quick answers
Who was awarded contract SPE2DR26FL8QH?
SPE2DR26FL8QH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FL8QH worth?
The government has obligated $11,897 on SPE2DR26FL8QH.
Is contract SPE2DR26FL8QH an order under another contract?
Yes. SPE2DR26FL8QH is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL8QH competed?
The extent of competition for SPE2DR26FL8QH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award